Cargando…
P245 Kaftrio® Impact and Side-effect Survey (KISS)
Autores principales: | Holden, A., Thickett, K., Sammons, L., Bird, K., Fitch, G., MacDuff, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184773/ http://dx.doi.org/10.1016/S1569-1993(22)00574-4 |
Ejemplares similares
-
P078 Adverse effects of Kaftrio® in an adult cystic fibrosis clinic
por: McCabe, D.
Publicado: (2022) -
M245. AN RCT PROTOCOL OF HYBRID-ECT FOR SCHIZOPHRENIA
por: Rong, Han
Publicado: (2020) -
Evaluating the Effect of Kaftrio on Perspectives of Health and Wellbeing in Individuals with Cystic Fibrosis
por: Aspinall, Sean A., et al.
Publicado: (2022) -
S245. BRAIN CONNECTIVITY CHANGES AFTER COGNITIVE REMEDIATION: A RESTING-STATE STUDY
por: Penadés, Rafael, et al.
Publicado: (2020) -
Delayed hepatic necrosis in a cystic fibrosis patient taking Elexacaftor/Tezacaftor/Ivacaftor (Kaftrio)
por: Salehi, Mahan, et al.
Publicado: (2021)